Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    18757090 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed GISSI-HF- Effects of n-3 PUFA and Rosuvastatin on Mortality-Morbidity of Patients With Symptomatic CHF
Condition: Heart Failure
Interventions: Drug: n-3 PUFA;   Drug: Rosuvastatin;   Drug: Placebo
2 Recruiting Nutritional Supplement Impact on Metabolic Parameters
Condition: Other Endocrine/Nutritional/Metabolic Disorder
Intervention: Dietary Supplement: Nutritional Supplement Blend

Indicates status has not been verified in more than two years